Stock JAN JANONE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases JanOne Inc.

Equities

JAN

US47089W1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
3.31 USD -1.19% Intraday chart for JanOne Inc. -2.65% +496.40%
May. 17 Exchange-Traded Funds, Equity Futures Tread Water Pre-Bell Friday Amid Waning September Rate Cut Hopes MT
May. 16 JanOne Closes Acquisition of Blockchain Fintech Firm -- Shares Fall After Hours MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech
PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
PR
JanOne Regains Compliance with Nasdaq's Listing Requirements
PR
JanOne to Present at the Dawson James 8th Annual Investment Conference
PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
PR
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
PR
JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain
PR
JANONE INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)
AQ
JanOne : Non-Reliance on Previously Issued Financial Report - Form 8-K
PU
JANONE INC. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)
AQ
JanOne Completes Pre-IND Meeting with FDA on Jan123
PR
JANONE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JAN Stock
  4. News JanOne Inc.
  5. Press Releases